1006711-90-5

Basic information

• Product Name: 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
• Synonyms: 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid
• CAS NO: 1006711-90-5
• Molecular Weight: 526.547
• Mol File: 1006711-90-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid(1006711-90-5)
• EPA Substance Registry System: 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid(1006711-90-5)

Safety Data

• Hazardous Substances Data: 1006711-90-5(Hazardous Substances Data)

Usage

Use in medicine

Chelating agent
It is used in the field of medicine to bind with metal ions in the body.

Derived from

EDTA (ethylenediaminetetraacetic acid)
A derivative of the chelating agent EDTA, which is a widely used compound in various applications.

Function

Removal of metal ions from the bloodstream
Helps to remove metal ions from the bloodstream, which can be useful in treating heavy metal poisoning and certain medical imaging procedures.

Composition

Multiple nitrogen and oxygen atoms
Contains multiple nitrogen and oxygen atoms that allow it to form stable complexes with a variety of metal ions.

Structure

Complex
The compound has a complex structure, which contributes to its suitability for various applications in medicine and biochemistry.

Upstream product

• 6118-51-0 exo-3,6-epoxy-1,2,3,6-tetrahydrophthalic anhydride 
• 944731-76-4 1,4,7,10-tetraazacyclododecane-1,4,7-tri(acetic acid)-10-((1,2-ethylenediamine monoamide)acetic acid) trifluroacetate 
• 137076-54-1 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane-10-acetic acid 
• 1613382-10-7 tri-tert-butyl 2,2',2''-(10-(2-((2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate 
• 122555-91-3 1,4,7-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane 
• 192635-89-5 phenylmethyl 2-(1,4,7,10-Tetraaza-4,7,10-tris(((tert-butyl)oxycarbonyl)methyl)cyclododecyl)-acetate 
• 294-90-6 1,4,7,10-tetraazacyclododecan 

Relevant articles and documents

Conjugates of the B-subunit of shiga toxin for use as contrasting agents for imaging and therapy

Multivalent conjugates comprising the following formula: (STxB-linker A-S)x-GNS-(S-linker B-T)y wherein STxB is the B-subunit of Shiga toxin; linker A is a noncleavable linker; linker B is a cleavable linker used to release at least

Bifunctional ligands based on the DOTA-monoamide cage

Efficient routes to DOTA-monoamide ligands bearing amino, hydroxyl, aldehyde and maleimido groups are described. These functional groups, which can be spaced at will from the coordination cage, will readily react with suitable groups of targeting moieties